The impact and challenges of the 2018 MHRA statement on the use of sodium valproate in women of childbearing age during the first year of implementation, in a UK epilepsy centre

Davies, P., Reuber, M. orcid.org/0000-0002-4104-6705, Grunewald, R. et al. (6 more authors) (2020) The impact and challenges of the 2018 MHRA statement on the use of sodium valproate in women of childbearing age during the first year of implementation, in a UK epilepsy centre. Seizure, 79. pp. 8-13. ISSN 1059-1311

Metadata

Item Type: Article
Authors/Creators:
Copyright, Publisher and Additional Information:

© 2020 British Epilepsy Association. Published by Elsevier Ltd. This is an author-produced version of a paper subsequently published in Seizure. Uploaded in accordance with the publisher's self-archiving policy. Article available under the terms of the CC-BY-NC-ND licence (https://creativecommons.org/licenses/by-nc-nd/4.0/).
Dates:
  • Published (online): 17 April 2020
  • Published: July 2020
Institution: The University of Sheffield
Academic Units: The University of Sheffield > Sheffield Teaching Hospitals
Depositing User: Symplectic Sheffield
Date Deposited: 11 May 2020 13:52
Last Modified: 17 Apr 2021 00:38
Status: Published
Publisher: Elsevier BV
Refereed: Yes
Identification Number: 10.1016/j.seizure.2020.03.015
Open Archives Initiative ID (OAI ID):

Export

Statistics


CORE (COnnecting REpositories)